KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Jazz Pharmaceuticals (JAZZ) over the last 12 years, with Dec 2024 value amounting to $845.0 million.

  • Jazz Pharmaceuticals' Change in Acquisitions & Divestments rose 12.68% to $400.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 82.61%. This contributed to the annual value of $845.0 million for FY2024, which is 212.96% up from last year.
  • According to the latest figures from FY2024, Jazz Pharmaceuticals' Change in Acquisitions & Divestments is $845.0 million, which was up 212.96% from $270.0 million recorded in FY2023.
  • Jazz Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $1.8 billion for FY2020, and its period low was $60.0 million during FY2022.
  • Over the past 3 years, Jazz Pharmaceuticals' median Change in Acquisitions & Divestments value was $270.0 million (recorded in 2023), while the average stood at $391.7 million.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Change in Acquisitions & Divestments slumped by 94.52% in 2022 and then surged by 350.00% in 2023.
  • Yearly analysis of 5 years shows Jazz Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.8 billion in 2020, then plummeted by 37.61% to $1.1 billion in 2021, then tumbled by 94.52% to $60.0 million in 2022, then soared by 350.00% to $270.0 million in 2023, then surged by 212.96% to $845.0 million in 2024.